Jazz Pharmaceuticals plc buy The Goldman Sachs Group, Inc.
Start price
03.03.23
/
50%
€137.36
Target price
03.03.24
€199.47
Performance (%)
-19.63%
End price
04.03.24
€110.40
Summary
This prediction ended on 04.03.24 with a price of €110.40. The price of Jazz Pharmaceuticals plc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.63%. The_Goldman_Sachs_Gr has a follow-up prediction for Jazz Pharmaceuticals plc where he still thinks Jazz Pharmaceuticals plc is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Jazz Pharmaceuticals plc | 2.841% | 2.841% | -13.395% |
iShares Core DAX® | -0.621% | 1.080% | 11.291% |
iShares Nasdaq 100 | -4.503% | -5.432% | 22.172% |
iShares Nikkei 225® | -2.562% | -1.617% | 7.262% |
iShares S&P 500 | -1.706% | -1.223% | 22.550% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $190.00 to $212.00. They now have a "buy" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
In the thread Trading Jazz Pharmaceuticals plc
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€98.06
05.06.24
05.06.24
€155.23
05.06.25
05.06.25
4.83%
29.07.24
29.07.24